Business Insights
Diagnostic Technologies
Diseases
Point-of-Care Testing
Research & Development
Sign In
Autoimmune
Cancer
Cardiovascular
COVID-19
Health Topics
Infectious
Infectious: Page 2
Cytokine improves outcomes in mice with sepsis, predicts survival in humans
By
Nick Paul Taylor
Administering a protein that correlates to survival in sepsis has improved survival in mice in a study, pointing to a potential new way to treat the life-threatening reaction to infection.
February 6, 2024
U.K. Health Security Agency unveils five-year pathogen genomics strategy
By
Matt Limb
The U.K. Health Security Agency (UKHSA) has unveiled a five-year plan to make pathogen genomics central to protecting public health and combating infectious disease threats.
February 1, 2024
Program to fight sepsis in LMICs launched at SCCM Congress, test data presented
By
Matt Limb
Intensive care professionals have unveiled a program to cut deaths from sepsis in low- and middle-income countries (LMICs) with ambitions to improve access to diagnostic tools, laboratories, and medicines.
January 26, 2024
Concentric by Ginkgo, Illumina to collaborate on biosurveillance technology
By
Matt Limb
Illumina and biosecurity firm Concentric by Ginkgo have pledged to expand biosecurity capabilities to help countries “modernize defenses" against emerging biological threats.
January 24, 2024
NowDiagnostics submits FDA de novo request for OTC syphilis test
By
LabPulse.com staff writers
NowDiagnostics has submitted a de novo authorization request to the U.S. Food and Drug Administration (FDA) for its First to Know over-the-counter (OTC) syphilis test.
January 10, 2024
FDA grants priority review to Merck’s pneumococcal vaccine
By
LabPulse.com staff writers
The U.S. Food and Drug Administration (FDA) has granted priority review to Merck’s experimental pneumococcal vaccine, with a decision to be made on approval by June 17, 2024.
December 20, 2023
AstraZeneca to buy Icosavax in agreement worth up to $1.1B
By
LabPulse.com staff writers
AstraZeneca has agreed to buy vaccine developer Icosavax in a deal worth up to $1.1 billion.
December 13, 2023
CDC awards contract to Quest Diagnostics to assess hepatitis C burden
By
LabPulse.com staff writers
Quest Diagnostics has been awarded a multiyear contract by the U.S. Centers for Disease Control and Prevention (CDC) to assess the burden of hepatitis C virus (HCV) in the U.S.
December 7, 2023
U.K. researchers use deep learning to develop rapid antimicrobial resistance test
By
Matt Limb
Researchers are hailing progress toward more rapid detection of antimicrobial resistance (AMR), with a susceptibility test returning results in 30 minutes.
December 1, 2023
Siemens Healthineers contracts with NIAID to develop NGS-based sepsis test
By
LabPulse.com staff writers
Siemens Healthineers has secured a three-year, $5.5 million contract with the National Institute of Allergy and Infectious Diseases (NIAID), a division of the U.S. National Institutes of Health, to develop a test to improve sepsis treatment.
November 22, 2023
Nanopore Technologies, Day Zero Diagnostics to collaborate on sepsis diagnostic solution
By
Matt Limb
Oxford, U.K.-based Oxford Nanopore Technologies and Boston-based infectious disease diagnostics firm Day Zero Diagnostics have announced a partnership to develop an end-to-end solution for the diagnosis of bloodstream infections.
November 20, 2023
Cytovale raises $84M in series C funding
By
LabPulse.com staff writers
Medical technology firm Cytovale has raised $84 million in a series C financing round that the firm says it will use to expand the commercialization of its 10-minute IntelliSep test.
November 16, 2023
Previous Page
Page 2 of 150
Next Page